tirzepatide surmount 3 The SURMOUNT-MAINTAIN trial will help answer the question of what to do with the obesity medication dose to maintain weight loss long-term Tirzepatide after intensive lifestyle intervention

Extended results from STEP 5 showed that participants maintained a 15.3% weight reduction at 104 weeks , reinforcing the drugs durability in supporting long-term health improvements

Different metabolic pathways

Semaglutide vs Surgery: Best Weight Loss Option

Both agree on a key point: obesity must now be addressed as a chronic inflammatory disease with systemic consequences, especially for the heart

Factors That May Influence Your Semaglutide Dosing Timeline Individual tolerance, body weight, insulin sensitivity, and genetic markers affecting GLP-1 receptor expression all influence how quickly you should escalate doses and how well you respond to standard weekly timing